This page has not yet been reviewed by a credentialed medical professional. It is educational and is not medical advice.
Why this evidence grade
Animal studies only
Strong lab data and some animal wound-healing work. Reviews note a "surprising absence" of clinical studies of GHK-Cu in wrinkle products, and no human data for injection.
What it is
GHK is a tripeptide (glycine-histidine-lysine) found naturally in human plasma, and it binds copper to form GHK-Cu. It is widely used as a cosmetic ingredient in serums and creams. Injectable GHK-Cu is also sold online as a "research chemical".
How it is thought to work
In cell studies, GHK-Cu stimulates collagen and glycosaminoglycan synthesis in fibroblasts and supports blood vessel and nerve outgrowth. A reviewer has argued gene-expression data point to broad effects on tissue remodelling, but those arguments are largely from the discoverer's group and rest on database analyses and cell work.
What the studies found7 studies explained
Cell work from the 1980s onward shows increased collagen synthesis. Mouse and rat models show faster wound healing, including with liposome-delivered GHK-Cu. For topical anti-wrinkle use, a 2025 review concluded cellular evidence is supportive but that there is a surprising absence of clinical studies, and that skin permeation is a real open question.
Cellular studies support GHK as an anti-wrinkle ingredient, but the reviewers found a surprising absence of clinical studies and raised open questions about skin permeation.
Pickart L, Margolina A · Int J Mol Sci · 2018 · PMID 29986520
reviewNarrative review
Who / how many
GHK biology and gene-expression data
What they found
Summarizes cell and animal evidence that GHK supports collagen and glycosaminoglycan synthesis, blood vessel and nerve outgrowth, and tissue repair, and proposes that gene-expression data explain its wide range of effects.
Limitations
Reviews findings largely from one research tradition, and mostly cell and animal work. Describes all of GHK's known actions as "health positive", which is stronger than the evidence supports.
Fu SC, Cheuk YC, Chiu WY · J Orthop Res · 2015 · PMID 25731775
animalRandomized animal experiment
Who / how many
72 rats after ACL reconstruction
What they found
Weekly intra-articular GHK-Cu injections for 4 weeks improved knee stability and graft stiffness at 6 weeks, but there was no significant difference at 12 weeks, and ultimate load, gait and histology did not differ.
Limitations
Benefits were temporary and lasted only while treatment continued. Rat knee model, local injection, and not tested in people.
Rats with wire-mesh wound chambers implanted under the skin
What they found
Injecting GHK-Cu into the chamber dose-dependently increased collagen, protein, DNA and glycosaminoglycan accumulation, and raised type I and III collagen mRNA. A control tripeptide had no effect.
Limitations
1993 rat wound-chamber model. It shows more connective tissue formed, not better healing of a real wound, and not in humans.
2 trials on ClinicalTrials.gov list GHK-Cu as an intervention; the most advanced are shown. Registration is not evidence of benefit: many trials are ongoing, unpublished or never reported results.
Data pulled from the ClinicalTrials.gov API. Check sponsors: several newer peptide registrations come from companies that also sell the product.
European research
143 records in Europe PMC mention GHK-Cu in the title or abstract. Of the 25 most-cited with European author affiliations that we sampled, the most common countries were France (7), Italy (7), Poland (6), Czech Republic (2).
Topical use is generally considered low risk; skin irritation is the usual concern. For injectable GHK-Cu there is no human safety data. Copper is an essential mineral but is toxic in excess, and unregulated injectables may vary in dose and purity.
Legal status
United States
Legal as a cosmetic ingredient in topical products. Injectable GHK-Cu is not an FDA-approved drug; its compounding status was part of FDA's April 2026 changes to the 503A interim list, so verify current rules.
Canada
Topical cosmetic use is allowed; injectable GHK-Cu is not an authorized drug in Canada.
European Union
Permitted as a cosmetic ingredient under EU cosmetics rules (check the CosIng database). Injectable GHK-Cu has no EMA authorization.
Sport (WADA)
Not listed as a named prohibited substance at the time of verification; check the current WADA Prohibited List.
Cell studies support a plausible effect on collagen, but a 2025 review found a surprising absence of clinical studies, and it is unclear how much GHK-Cu actually penetrates skin.
Is injectable GHK-Cu proven?
No. There are no controlled human studies of injected GHK-Cu for skin, hair or healing.
